Zanubrutinib
Back to searchMolecule Structure
Scientific Name
Zanubrutinib
Description of the Drug
Zanubrutinib is a kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15035
http://www.drugbank.ca/drugs/DB15035
Brand Name(s)
Brukinsa
Company Owner(s)
Beigene Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tyrosine-protein kinase BTK | SINGLE PROTEIN | INHIBITOR | CHEMBL5251 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL17842597 | |
Human Metabolome Database | HMDB0304875 | |
DrugBank | DB15035 | |
PubChem | 135565884 | |
BindingDB | 250082 | |
DrugCentral | 5353 | |
ChemicalBook | CB93361383 | |
rxnorm | BRUKINSA | ZANUBRUTINIB |
ZINC | ZINC000584641430 |